Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Failure in Critical Therapy(INFECT) Study: Phenotyping Immune Cell Dysfunction to Predict Outcomes in Critically Ill Adults

NCT02186522 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT02186522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02186522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Failure in Critical Therapy(INFECT) Study: Phenotyping Immune Cell Dysfunction to Predict Outcomes in Critically Ill Adults
Lead sponsor
University of Edinburgh
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
January 31, 2016
Enrollment
168 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock